Patents Assigned to TheraNova, LLC
  • Patent number: 7896823
    Abstract: Devices that employ external compression stocking-type garments in the treatment of edema, chronic wounds, deep venous thrombosis prevention or claudication all share a number of significant limitations. These include the frequent need for custom fitting to assure an appropriate fit, vigilant maintenance to assure a continued “good fit,” limited compliance with proper use by patients and difficulty of application. There is a large body of evidence demonstrating that patients often decline to wear the compressive stockings as prescribed or in the form that would be most beneficial because they find these devices to be difficult to put on and take off. Building on the limitations of existing therapies, and distilled lessons learned from the field of prosthetics and wound healing, the present invention employs vacuum-assisted negative pressure to provide compression and help pump fluid from the tissues of affected limbs.
    Type: Grant
    Filed: January 17, 2006
    Date of Patent: March 1, 2011
    Assignee: TheraNova, LLC
    Inventors: Shane Mangrum, Daniel Burnett
  • Patent number: 7850704
    Abstract: Methods, devices and systems facilitate retention of a variety of therapeutic devices. Devices generally include an anchoring element, which has been designed to promote fibrotic ingrowth, and an anchored device, which has been designed to firmly engage the complementary region of the anchoring element. The anchoring element may be placed in a minimally invasive procedure temporally separated from the deployment of the anchored device. Once enough time has passed to ensure appropriate fixation of the anchoring element by tissue and cellular ingrowth at the site of placement, the anchored device may then be deployed during which it firmly engages the complementary region of the anchoring element. In this manner, a firm attachment to the implantation site may be made with a minimum of required hardware. Some embodiments are delivered through a delivery tube or catheter and while some embodiments may require laparoscopy or open surgery for one or more of the placement procedures.
    Type: Grant
    Filed: September 26, 2005
    Date of Patent: December 14, 2010
    Assignee: TheraNova, LLC
    Inventors: Daniel Rogers Burnett, Shane Mangrum
  • Patent number: 7597101
    Abstract: The present invention may create and maintain a pressure differential in the vicinity of the user's nasopharynx. A portable filter and pressurized air source subjects the region of the user's nasopharynx to positive or negative pressured air. Positive pressure prevents exposure to surrounding air while negative pressure isolates those around the user from potential toxins or pathogens exhaled from the user. With positive pressure, surrounding air is displaced preventing exposure to ambient air in most instances. With negative pressure, exhaled air is evacuated from the nasopharynx, filtered and returned to the user's surroundings to prevent exposure to those around the user. Such devices may be incorporated into garments, accessories or existing isolation devices (e.g., face masks) to improve efficacy. Alternatively, the device may also be attached to an air source in the user's vicinity and provide filtration of the air prior to delivery to the region surrounding the user.
    Type: Grant
    Filed: January 17, 2006
    Date of Patent: October 6, 2009
    Assignee: TheraNova, LLC
    Inventors: Daniel Rogers Burnett, Shane Mangrum
  • Publication number: 20090030435
    Abstract: Methods, devices and systems facilitate retention of a variety of therapeutic devices. Devices generally include an anchoring element, which has been designed to promote fibrotic ingrowth, and an anchored device, which has been designed to firmly engage the complementary region of the anchoring element. The anchoring element may be placed in a minimally invasive procedure temporally separated from the deployment of the anchored device. Once enough time has passed to ensure appropriate fixation of the anchoring element by tissue and cellular ingrowth at the site of placement, the anchored device may then be deployed during which it firmly engages the complementary region of the anchoring element. In this manner, a firm attachment to the implantation site may be made with a minimum of required hardware. Some embodiments are delivered through a delivery tube or catheter and while some embodiments may require laparoscopy or open surgery for one or more of the placement procedures.
    Type: Application
    Filed: August 15, 2008
    Publication date: January 29, 2009
    Applicant: TheraNova, LLC
    Inventors: Daniel Rogers BURNETT, Shane MANGRUM
  • Publication number: 20070167884
    Abstract: Devices that employ external compression stocking-type garments in the treatment of edema, chronic wounds, deep venous thrombosis prevention or claudication all share a number of significant limitations. These include the frequent need for custom fitting to assure an appropriate fit, vigilant maintenance to assure a continued “good fit,” limited compliance with proper use by patients and difficulty of application. There is a large body of evidence demonstrating that patients often decline to wear the compressive stockings as prescribed or in the form that would be most beneficial because they find these devices to be difficult to put on and take off. Building on the limitations of existing therapies, and distilled lessons learned from the field of prosthetics and wound healing, the present invention employs vacuum-assisted negative pressure to provide compression and help pump fluid from the tissues of affected limbs.
    Type: Application
    Filed: January 17, 2006
    Publication date: July 19, 2007
    Applicant: THERANOVA, LLC
    Inventors: Shane Mangrum, Daniel Burnett
  • Publication number: 20070167990
    Abstract: Current treatment options for Overactive Bladder and Urinary Incontinence include exercise and behavioral modifications, pharmacological therapies, surgical intervention, and neuromodulation. Although each of these treatments is used in the treatment of individuals with these conditions, each has severe limitations. Building on the limitations of existing therapies, and with the distillation of lessons learned from the field of pulsed electric stimulation, the present invention employs Low Frequency Induction Therapy for the delivery of an effective, cost efficient, noninvasive alternative to available treatment options. The device of the present application allows for consistent, user-friendly modulation of the pudendal nerve and the sacral plexus, via pulsed electromagnetic stimulation of the posterior tibial nerve, on an outpatient basis.
    Type: Application
    Filed: January 17, 2006
    Publication date: July 19, 2007
    Applicant: THERANOVA, LLC
    Inventors: Shane Mangrum, Daniel Burnett
  • Publication number: 20070163586
    Abstract: The device of the present invention may create and maintain a pressure differential in the vicinity of the user's nasopharynx. Using a portable filter and pressurized air source, the region of the user's nasopharynx can be subjected to positive or negative pressured air. Positive pressure will prevent exposure surrounding air while negative air pressure will isolate those around the user from potential toxins or pathogens exhaled from the user. In the positive pressure embodiments, the surrounding air may be displaced by the positive pressure environment preventing exposure to ambient air in all instances other than a direct blast of high flow air directed at the users nasopharynx (such as an uncovered and maliciously directed sneeze). If adequate pressure is used, though, even this scenario would not allow for transmission of airborne illness with repulsion of any infective droplets being repelled by the positive pressure created.
    Type: Application
    Filed: January 17, 2006
    Publication date: July 19, 2007
    Applicant: THERANOVA, LLC
    Inventors: Daniel Burnett, Shane Mangrum
  • Publication number: 20070093697
    Abstract: The present invention provides a rapid, economical test for the detection of a right to left shunt applicable to the population at large due to its safety and noninvasiveness. The intended procedure involves gaining access to the circulatory system, injecting a measurable substance, ideally during prolonged and/or repeated Valsalva maneuvers, and then rapidly and repeatedly, ideally continuously, assaying for the substance. Through the determination of the appearance of a small amount of the substance prior to the subsequent high concentrations generated by the remainder of the bolus, one may safely diagnose a meaningful communication between the right and left heart, or other right to left shunt bypassing the lungs.
    Type: Application
    Filed: January 17, 2006
    Publication date: April 26, 2007
    Applicant: THERANOVA, LLC
    Inventors: Daniel Burnett, Shane Mangrum
  • Publication number: 20060069400
    Abstract: Methods, devices and systems facilitate retention of a variety of therapeutic devices. Devices generally include an anchoring element, which has been designed to promote fibrotic ingrowth, and an anchored device, which has been designed to firmly engage the complementary region of the anchoring element. The anchoring element may be placed in a minimally invasive procedure temporally separated from the deployment of the anchored device. Once enough time has passed to ensure appropriate fixation of the anchoring element by tissue and cellular ingrowth at the site of placement, the anchored device may then be deployed during which it firmly engages the complementary region of the anchoring element. In this manner, a firm attachment to the implantation site may be made with a minimum of required hardware. Some embodiments are delivered through a delivery tube or catheter and while some embodiments may require laparoscopy or open surgery for one or more of the placement procedures.
    Type: Application
    Filed: September 26, 2005
    Publication date: March 30, 2006
    Applicant: THERANOVA, LLC
    Inventors: Daniel Burnett, Shane Mangrum
  • Publication number: 20060036208
    Abstract: An implantable fluid management device, designed to drain excess fluid from a variety of locations in a living host into a second location within the host, such as the bladder of that host. The device may be used to treat ascites, chronic pericardial effusions, normopressure hydrocephalus, hydrocephalus, pulmonary edema, or any fluid collection within the body of a human, or a non-human mammal.
    Type: Application
    Filed: August 4, 2005
    Publication date: February 16, 2006
    Applicant: THERANOVA LLC
    Inventor: Daniel Burnett